Form 4: DiaMedica Therapeutics Director Acquires Stock Options
SEC Form 4 Filing
Director Tanya Lewis acquires stock options in DiaMedica Therapeutics, vesting quarterly over one year.
Summary
- On June 1, 2024, Tanya Lewis, a director of DiaMedica Therapeutics Inc., acquired 28,472 stock options.
- The options have an exercise price of $2.90.
- The options vest in four nearly equal quarterly installments over one year.
- The expiration date for these options is May 31, 2034.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a standard disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the compensation and holdings of company directors.
Key Dates
| Date | Description |
|---|---|
| 06/01/2024 | Date of transaction: Tanya Lewis acquired stock options. |
| 06/03/2024 | Date of signature on the Form 4 filing. |
| 05/31/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.